Literature DB >> 21172679

Asthma and chronic sickle cell lung disease: a dynamic relationship.

N R Shilo1, L C Lands.   

Abstract

Chronic lung disease is a significant source of morbidity and mortality in patients with sickle cell disease. Asthma and sickle cell lung disease share many of the same clinical features and pathophysiological mechanisms. Though there is growing evidence of an association between sickle cell disease and airway hyper-reactivity, there is still no consensus on the definition of asthma in sickle cell lung disease. This review will explore what we know about asthma and airway hyper-reactivity in sickle cell disease and whether currently available asthma therapies may be beneficial in delaying or averting the progression of sickle cell lung disease. 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21172679     DOI: 10.1016/j.prrv.2010.09.007

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  7 in total

Review 1.  Asthma morbidity and treatment in children with sickle cell disease.

Authors:  Samuel O Anim; Robert C Strunk; Michael R DeBaun
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

2.  Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease.

Authors:  Robyn T Cohen; Anusha Madadi; Morey A Blinder; Michael R DeBaun; Robert C Strunk; Joshua J Field
Journal:  Am J Hematol       Date:  2011-08-02       Impact factor: 10.047

3.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

4.  Progression and prognostic indicators of bronchial disease in children with sickle cell disease.

Authors:  Sophia N Williams; Eliezer Nussbaum; Leila Yoonessi; Tricia Morphew; Inderpal Randhawa
Journal:  Lung       Date:  2014-04-04       Impact factor: 2.584

Review 5.  Secondhand Smoke Is an Important Modifiable Risk Factor in Sickle Cell Disease: A Review of the Current Literature and Areas for Future Research.

Authors:  S Christy Sadreameli; Benjamin T Kopp; Susan E Creary; Michelle N Eakin; Sharon McGrath-Morrow; John J Strouse
Journal:  Int J Environ Res Public Health       Date:  2016-11-12       Impact factor: 3.390

6.  Variation in pulmonary function tests among children with sickle cell anemia: a systematic review and meta-analysis.

Authors:  Amar Taksande; Patel Zeeshan Jameel; Divya Pujari; Bharati Taksande; Revat Meshram
Journal:  Pan Afr Med J       Date:  2021-06-18

Review 7.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.